Extubation Advisor (EA)
AI-driven decision support for predicting extubation outcomes in ICU patients
Company profile
Company profile
OBS Medical is a UK-based health technology company that manufactures and distributes clinical decision support software (CDSS) designed to help healthcare professionals manage and monitor complex health conditions more effectively. The company's flagship product, Visensia, is an interoperability and analytics platform that combines clinical data from legacy patient monitoring infrastructure with the latest wearable and sensor technology, displaying it via a single intuitive clinical dashboard. The Visensia Safety Index uses artificial intelligence and predictive analytics to provide early recognition and response to clinical deterioration in hospital patients, helping to prioritise clinical workflow, empower point-of-care teams, and predict and prevent critical crises. OBS Medical serves hospitals, emergency medical services, home monitoring/virtual wards, and remote patient monitoring applications. The company partners with leading healthcare organisations, hospital data service providers, and medical device manufacturers including Baxter-Hillrom, Therapeutic Monitoring Systems, QRS, and Qardio. Their technology has received regulatory clearances including Health Canada authorisation and FDA clearance through partner integrations. OBS Medical's mission is to deliver clinical information that saves lives and improves workflow through simplification, risk identification, and prevention.
Company description OBS MEDICAL official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Hybrid · On Premise deployment with recorded integration context.
Recorded integration context: Baxter-Hillrom WAVE Clinical Platform, Excel Medical Electronics, Legacy patient monitoring systems, Qardio wearables, QRS medical equipment, Therapeutic Monitoring Systems.
Company milestones
Health Canada authorisation for Visensia (April 2024), Partnership with Nihon Kohden for Japan market (March 2021), Partnership with Therapeutic Monitoring Systems for Extubation Advisor (June 2021), QardioMD+VSI remote monitoring solution launch (May 2020)
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-driven decision support for predicting extubation outcomes in ICU patients
Remote monitoring combining Qardio wearables with Visensia predictive algorithms
AI-powered clinical decision support for early detection of patient deterioration
Remote patient monitoring solution for virtual wards and home care
Inpatient monitoring solution for early detection of clinical deterioration
Mobile clinical decision support for emergency medical services
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of medical Internet research · May 8, 2026
Can Early Warning Systems Enhance Detection of High Risk Patients by Rapid Response Teams?Journal of intensive care medicine · May 1, 2021
A fundamental relationship between intraventricular conduction and heart rate.Journal of electrocardiology · Jan 1, 2016
Automated QT analysis that learns from cardiologist annotations.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · Jan 1, 2009
Clinical validation
No linked records are currently available.
Regulatory
K081140 · 510k · Jul 17, 2008
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Hospital research with continuous monitoring
In-hospital patients
ICU mechanically ventilated patients
Continuous monitoring to reduce ICU transfers
One third fewer transfers to intensive care
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on OBS MEDICAL's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.